Evidence for placebo effects on physical but not on biochemical outcome parameters: A review of clinical trials

BMC Medicine

Volumn 5, Issue , 2007, Pages

  Meissner, Karin ^a   Distel, Hans ^a   Mitzdorf, Ulla ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ANUS FISSURE; ASTHMA; BIOCHEMISTRY; BLOOD PRESSURE; CHRONIC BRONCHITIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; CROHN DISEASE; DIABETES MELLITUS; DISEASE COURSE; ESOPHAGUS ACHALASIA; FORCED EXPIRATORY VOLUME; HEART FAILURE; HEPATITIS C; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LEG ULCER; MEDLINE; META ANALYSIS; ORTHOSTATIC HYPOTENSION; OUTCOMES RESEARCH; PHYSICAL DISEASE; PREGNANCY; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ENDPOINT DETERMINATION; HUMANS; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 34147141335     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-5-3     Document Type: Review

References (87)

1. Kaptchuk TJ Powerful placebo: The dark side of the randomised controlled trial Lancet 1998 351 1722-1725 10.1016/S0140-6736(97)10111-8 9734904
2. Kienle GS Kiene H The powerful placebo effect: Fact or fiction? Clin Epidemiol 1997 50 1311-1318 10.1016/S0895-4356(97)00203-5
3. Ernst E Concept of true and perceived placebo effects BMJ 1995 311 551-553 7663213
4. Hrobjartsson A Gotzsche PC Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment N Engl J Med 2001 344 1594-1602 10.1056/NEJM200105243442106 11372012
5. Hrobjartsson A Gotzsche PC Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment J Intern Med 2004 256 91-100 10.1111/ j.1365-2796.2004.01355.x 15257721
6. Hrobjartsson A Gotzsche PC Placebo interventions for all clinical conditions Cochrane Database Syst Rev 2004 CD003974 15266510
7. Meissner K Preferring patient-reported to observer-reported outcomes substantially influences the results of the updated systematic review on placebos by Hrobjartsson and Gotzsche J Intern Med 2005 257 394 15788014
8. Pasricha PJ Ravich WJ Hendrix TR Sostre S Jones B Kalloo AN Intrasphincteric botulinum toxin for the treatment of achalasia N Engl J Med 1995 332 774-778 10.1056/NEJM199503233321203 7862180
9. Lund JN Scholefield JH A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure Lancet 1997 349 11-14 10.1016/S0140-6736(96)06090-4 8988115
10. D'Alonzo GE Nathan RA Henochowicz S Morris RJ Ratner P Rennard SI Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma Jama 1994 271 1412-1416 10.1001/jama.271.18.1412 7909853
11. Israel E Rubin P Kemp JP Grossman J Pierson W Siegel SC Tinkelman D Murray JJ Busse W Segal AT Fish J Kaiser HB Ledford D Wenzel S Rosenthal R Cohn J Lanni C Pearlman H Karahalios P Drazen JM The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma Ann Intern Med 1993 119 1059-1066 8239223
12. Knorr B Matz J Bernstein JA Nguyen H Seidenberg BC Reiss TF Becker A Montelukast for chronic asthma in 6- to 14-year-old children: A randomized, double-blind trial. Pediatric Montelukast Study Group Jama 1998 279 1181-1186 10.1001/jama.279.15.1181 9555757
13. Leff JA Busse WW Pearlman D Bronsky EA Kemp J Hendeles L Dockhorn R Kundu S Zhang J Seidenberg BC Reiss TF Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction N Engl J Med 1998 339 147-152 10.1056/NEJM199807163390302 9664090
14. Tamaoki J Kondo M Sakai N Aoshiba K Tagaya E Nakata J Isono K Nagai A Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: A double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group Lancet 2000 356 273-278 10.1016/ S0140-6736(00)02501-0 11071181
15. Berges RR Windeler J Trampisch HJ Senge T Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group Lancet 1995 345 1529-1532 10.1016/S0140-6736(95)91085-9 7540705
16. Gormley GJ Stoner E Bruskewitz RC Imperato-McGinley J Walsh PC McConnell JD Andriole GL Geller J Bracken BR Tenover JS Vaughan ED Pappas F Taylor A Binkowitz B Jennifer NG The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group N Engl J Med 1992 327 1185-1191 1383816
17. Lepor H Williford WO Barry MJ Brawer MK Dixon CM Gormley G Haakenson C Machi M Narayan P Padley RJ The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group N Engl J Med 1996 335 533-539 10.1056/NEJM199608223350801 8684407
18. Anzueto A Jubran A Ohar JA Piquette CA Rennard SI Colice G Pattishall EN Barrett J Engle M Perret KA Rubin BK Effects of aerosolized surfactant in patients with stable chronic bronchitis: A prospective randomized controlled trial Jama 1997 278 1426-1431 10.1001/jama.278.17.1426 9356001
19. Duffy SJ Gokce N Holbrook M Huang A Frei B Keaney JF Jr Vita JA Treatment of hypertension with ascorbic acid Lancet 1999 354 2048-2049 10.1016/S0140-6736(99)04410-4 10636373
20. Materson BJ Reda DJ Cushman WC Massie BM Freis ED Kochar MS Hamburger RJ Fye C Lakshman R Gottdiener J Ramirez EA Henderson WG Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents N Engl J Med 1993 328 914-921 10.1056/NEJM199304013281303 8446138
21. Siegel D Hulley SB Black DM Cheitlin MD Sebastian A Seeley DG Hearst N Fine R Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men Jama 1992 267 1083-1089 10.1001/jama.267.8.1083 1735925
22. Toft I Bonaa KH Ingebretsen OC Nordoy A Jenssen T Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial Ann Intern Med 1995 123 911-918 7486485
23. Low PA Gilden JL Freeman R Sheng KN McElligott MA Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group Jama 1997 277 1046-1051 10.1001/jama.277.13.1046 9091692
24. Ezzat S Snyder PJ Young WF Boyajy LD Newman C Klibanski A Molitch ME Boyd AE Sheeler L Cook DM Malarkey WB Jackson I Vance ML Thorner MO Barkan A Frohman LA Melmed S Octreotide treatment of acromegaly. A randomized, multicenter study Ann Intern Med 1992 117 711-718 1416572
25. Trainer PJ Drake WM Katznelson L Freda PU Herman-Bonert V van der Lely AJ Dimaraki EV Stewart PM Friend KE Vance ML Besser GM Scarlett JA Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant N Engl J Med 2000 342 1171-1177 10.1056/NEJM200004203421604 10770982
26. Kiowski W Sutsch G Hunziker P Muller P Kim J Oechslin E Schmitt R Jones R Bertel O Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure Lancet 1995 346 732-736 10.1016/ S0140-6736(95)91504-4 7658874
27. Khatta M Alexander BS Krichten CM Fisher ML Freudenberger R Robinson SW Gottlieb SS The effect of coenzyme Q10 in patients with congestive heart failure Ann Intern Med 2000 132 636-640 10766682
28. Di Bisceglie AM Conjeevaram HS Fried MW Sallie R Park Y Yurdaydin C Swain M Kleiner DE Mahaney K Hoofnagle JH Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial Ann Intern Med 1995 123 897-903 7486483
29. Shindo M Di Bisceglie AM Cheung L Shih JW Cristiano K Feinstone SM Hoofnagle JH Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C Ann Intern Med 1991 115 700-704 1656828
30. Stephens NG Parsons A Schofield PM Kelly F Cheeseman K Mitchinson MJ Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet 1996 347 781-786 10.1016/S0140-6736(96)90866-1 8622332
31. Greenberg GR Feagan BG Martin F Sutherland LR Thomson AB Williams CN Nilsson LG Persson T Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group N Engl J Med 1994 331 836-841 10.1056/NEJM199409293311303 8078529
32. Targan SR Hanauer SB van Deventer SJ Mayer L Present DH Braakman T DeWoody KL Schaible TF Rutgeerts PJ A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group N Engl J Med 1997 337 1029-1035 10.1056/NEJM199710093371502 9321530
33. Acerini CL Patton CM Savage MO Kernell A Westphal O Dunger DB Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus Lancet 1997 350 1199-1204 10.1016/ S0140-6736(97)06467-2 9652560
34. Betteridge DJ Bhatnager D Bing RF Durrington PN Evans GR Flax H Jay RH Lewis-Barned N Mann J Matthews DR Miller JP Reckless JPD Sturley R Taylor KG Winder AF Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine Bmj 1992 304 1335-1338 1611329
35. Miettinen TA Puska P Gylling H Vanhanen H Vartiainen E Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population N Engl J Med 1995 333 1308-1312 10.1056/ NEJM199511163332002 7566021
36. Sattar N Perera M Small M Lumsden MA Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes Lancet 1999 354 487-488 10.1016/S0140-6736(99)02079-6 10465182
37. Silverberg SJ Bone HG 3rd Marriott TB Locker FG Thys-Jacobs S Dziem G Kaatz S Sanguinetti EL Bilezikian JP Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism N Engl J Med 1997 337 1506-1510 10.1056/ NEJM199711203372104 9366582
38. Raz R Stamm WE A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections N Engl J Med 1993 329 753-756 10.1056/NEJM199309093291102 8350884
39. Clark P Casas E Tugwell P Medina C Gheno C Tenorio G Orozco JA Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial Ann Intern Med 1993 119 1067-1071 8239224
40. Simon LS Weaver AL Graham DY Kivitz AJ Lipsky PE Hubbard RC Isakson PC Verburg KM Yu SS Zhao WW Geis GS Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial Jama 1999 282 1921-1928 10.1001/ jama.282.20.1921 10580457
41. Herouy Y Hellstern MO Vanscheidt W Schopf E Norgauer J Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers Lancet 2000 355 1970-1971 10.1016/S0140-6736(00)02333-3 10859047
42. Godfrey S Silverman M Demonstration by placebo response in asthma by means of exercise testing J Psychosom Res 1973 17 293-297 10.1016/ 0022-3999(73)90106-2 4206466
43. May O Hansen NC Comparison of terbutaline, isotonic saline, ambient air and non-treatment in patients with reversible chronic airway obstruction Eur Respir J 1988 1 527-530 3169222
44. Morton AR Fazio SM Miller D Efficacy of laser-acupuncture in the prevention of exercise-induced asthma Ann Allergy 1993 70 295-298 8466094
45. Nawrocki JD Bell TJ Lawrence WT Ward JP A randomized controlled trial of transurethral microwave thermotherapy Br J Urol 1997 79 389-393 9117220
46. Diamond L Dockhorn RJ Grossman J Kisicki JC Posner M Zinny MA Koker P Korts D Wecker MT A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold J Allergy Clin Immunol 1995 95 1139-1146 10.1016/S0091-6749(95)70219-9 7751531
47. Hayden FG Diamond L Wood PB Korts DC Wecker MT Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial Ann Intern Med 1996 125 89-97 8678385
48. Blades KJ Patel S Aidoo KE Oral antioxidant therapy for marginal dry eye Eur J Clin Nutr 2001 55 589-597 10.1038/sj.ejcn.1601186 11464232
49. Antivalle M Lattuada S Salvaggio A Paravicini M Rindi M Libretti A Placebo effect and adaptation to noninvasive monitoring of BP J Hum Hypertens 1990 4 633-637 2096204
50. Asmar R Boutelant S Chaignon M Guedon J Topouchian J Mallion JM Safar M Repeated measurements of non-invasive ambulatory blood pressure: distinction between reproducibility and the proper effect of placebo Blood Press Monit 1996 1 283-288 10226245
51. Bosley F Allen TW Stress management training for hypertensives: cognitive and physiological effects J Behav Med 1989 12 77-89 10.1007/ BF00844750 2746644
52. Canino E Cardona R Monsalve P Perez Acuna F Lopez B Fragachan F A behavioral treatment program as a therapy in the control of primary hypertension Acta Cient Venez 1994 45 23-30 8525757
53. Frankel BL Patel DJ Horwitz D Friedewald WT Gaarder KR Treatment of hypertension with biofeedback and relaxation techniques Psychosom Med 1978 40 276-293 356078
54. Hossmann V FitzGerald GA Dollery CT Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertension Hypertension 1981 3 113-118 7009424
55. Rossi A Ziacchi V Lomanto B The hypotensive effect of a single daily dose of labetalol: A preliminary study Int J Clin Pharmacol Ther Toxicol 1982 20 438-445 6754634
56. Seer P Raeburn JM Meditation training and essential hypertension: A methodological study J Behav Med 1980 3 59-71 10.1007/BF00844914 6995617
57. Sinaiko AR Gomez-Marin O Prineas RJ Effect of low sodium diet or potassium supplementation on adolescent blood pressure Hypertension 1993 21 989-994 8505112
58. Yates RG Lamping DL Abram NL Wright C Effects of chiropractic treatment on blood pressure and anxiety: A randomized, controlled trial J Manipulative Physiol Ther 1988 11 484 -88 3075649
59. GRECHO Evaluation of 2 homeopathic products on the resumption of transit after digestive surgery. A multicenter controlled trial Presse Med 1989 18 59-62 2521722
60. Hashish BI Harvey W Harris M Anti-inflammatory effects of ultrasound therapy: Evidence for a major placebo effect British Journal of Rheumatology 1986 25 77-81 10.1093/rheumatology/25.1.77 2417648
61. Hashish I Hai HK Harvey W Feinmann C Harris M Reduction of postoperative pain and swelling by ultrasound treatment: A placebo effect Pain 1988 33 303-311 10.1016/0304-3959(88)90289-8 3419838
62. Crosby L Palarski VA Cottington E Cmolik B Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: A randomized, placebo-controlled study Heart Lung 1994 23 493-499 7852064
63. Anderson BJ Brackett J Ho J Laffel LM An intervention to promote family teamwork in diabetes management tasks: Relationships among parental involvement, adherence to blood glucose monitoring, and glycemic control in young adolescents with type 1 diabetes Promoting adherence to medical treatment in chronic childhood illness: Concepts, methods and interventions Mahwah: Lawrence Erlbaum Associates 2000 347-365
64. Lindholm LH Ekbom T Dash C Isacsson A Schersten B Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: The main results of the CELL Study J Intern Med 1996 240 13-22 10.1046/j.1365-2796.1996.492831000.x 8708586
65. Tuomilehto J Voutilainen E Huttunen J Vinni S Homan K Effect of guar gum on body weight and serum lipids in hypercholesterolemic females Acta Med Scand 1980 208 45-48 7435246
66. Karunakaran S Hammersley MS Morris RJ Turner RC Holman RR The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose Metabolism 1997 46 56-60 10.1016/S0026-0495(97)90319-X 9439561
67. Andersen NA Damm P Tabor A Pedersen IM Harring M Prevention of breast pain and milk secretion with bromocriptine after second-trimester abortion Acta Obstet Gynecol Scand 1990 69 235-238 2220345
68. Davis CE The effect of regression to the mean in epidemiologic and clinical studies Am J Epidemiol 1976 104 493-498 984023
69. Jones GE Perception of visceral sensations: A review of recent findings, methodologies, and future directions Advances in psychophysiology London: Kingsley Jennings JR, Ackles PK, Coles MGH 1994 5 55-191
70. Manning HL Schwartzstein RM Respiratory sensations in asthma: physiological and clinical implications J Asthma 2001 38 447-460 10.1081/ JAS-100105865 11642411
71. O'Brien WH Reid GJ Jones KR Differences in heartbeat awareness among males with higher and lower levels of systolic blood pressure Int J Psychophysiol 1998 29 53-63 10.1016/S0167-8760(98)00004-X 9641248
72. Allan LG Siegel S A signal detection theory analysis of the placebo effect Eval Health Prof 2002 25 410-420 10.1177/0163278702238054 12449084
73. Miller NE Learning of visceral and glandular responses Science 1969 163 434-445 10.1126/science.163.3866.434 5812527
74. de la Fuente-Fernandez R Schulzer M Stoessl AJ Placebo mechanisms and reward circuitry: Clues from Parkinson's disease Biol Psychiatry 2004 56 67-71 10.1016/j.biopsych.2003.11.019 15231437
75. Cechetto DF Saper CB Evidence for a viscerotopic sensory representation in the cortex and thalamus in the rat J Comp Neurol 1987 262 27-45 10.1002/cne.902620104 2442207
76. Cechetto DF Role of the cerebral cortex in autonomic function Central Regulation of Autonomic Functions Oxford, UK: Oxford University Press Loewy AD, Spyer KM 1990 208-223
77. Schandry R Leopold C Vogt M Symptom reporting in asthma patients and insulin-dependent diabetics Biol Psychol 1996 42 231-244 10.1016/ 0301-0511(95)05157-0 8770381
78. Wagner K Neuringer A Operant variability when reinforcement is delayed Learn Behav 2006 34 111-123 16933797
79. Klosterhalfen S Enck P Psychobiology of the placebo response Auton Neurosci 2006 125 94-99 10.1016/j.autneu.2006.01.015 16515893
80. Benedetti F Mayberg HS Wager TD Stohler CS Zubieta JK Neurobiological mechanisms of the placebo effect J Neurosci 2005 25 10390-10402 10.1523/ JNEUROSCI.3458-05.2005 16280578
81. Watanabe M Cromwell HC Tremblay L Hollerman JR Hikosaka K Schultz W Behavioral reactions reflecting differential reward expectations in monkeys Exp Brain Res 2001 140 511-518 10.1007/s002210100856 11685405
82. de La Fuente-Fernandez R Stoessl AJ The biochemical bases for reward. Implications for the placebo effect Eval Health Prof 2002 25 387-398 10.1177/0163278702238052 12449082
83. Kirsch I The placebo effect as a conditioned response: Failures of the "litmus test" Behavioral and Brain Sciences 1991 14 200-204
84. Levine ME Stern RM Koch KL The effects of manipulating expectations through placebo and nocebo administration on gastric tachyarrhythmia and motion-induced nausea Psychosom Med 2006 68 478-486 10.1097/ 01.psy.0000221377.52036.50 16738082
85. Meissner K Gluender H Mitzdorf U Placebo effects on gastric slow wave frequency [abstract] Psychophysiology 2005 42 S15-S16 10.1111/ j.1469-8986.2005.00328.x
86. Leigh R MacQueen G Tougas G Hargreave FE Bienenstock J Change in forced expiratory volume in 1 second after sham bronchoconstrictor in suggestible but not suggestion-resistant asthmatic subjects: A pilot study Psychosom Med 2003 65 791-795 10.1097/01.PSY.0000079454.48714.1B 14508022
87. Benedetti F Pollo A Lopiano L Lanotte M Vighetti S Rainero I Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses J Neurosci 2003 23 4315-4323 12764120